US FDA grants approval to Ultragenyx Pharmaceutical for Crysvita
The drug has been approved to treat patients with tumor-induced osteomalacia (TIO), a rare disease that is characterized by the…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.